Mirae Asset Global Investments Co. Ltd. Has $10.01 Million Holdings in HCA Healthcare, Inc. $HCA

Mirae Asset Global Investments Co. Ltd. lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 5.5% during the third quarter, Holdings Channel reports. The fund owned 23,475 shares of the company’s stock after selling 1,362 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in HCA Healthcare were worth $10,005,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in HCA. Ameriflex Group Inc. acquired a new position in HCA Healthcare in the 2nd quarter valued at $27,000. Chung Wu Investment Group LLC acquired a new stake in HCA Healthcare during the second quarter worth about $27,000. Clearstead Trust LLC raised its position in HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after purchasing an additional 53 shares in the last quarter. Harbor Capital Advisors Inc. boosted its stake in HCA Healthcare by 82.9% in the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after buying an additional 34 shares in the last quarter. Finally, Twin Peaks Wealth Advisors LLC bought a new stake in shares of HCA Healthcare during the 2nd quarter valued at approximately $40,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Strong quarterly results and market reaction — HCA reported an EPS beat and raised FY 2026 guidance, prompting coverage noting a gap up in the stock after the print. Shares Gap Up on Strong Earnings
• Positive Sentiment: Analysts boost targets and maintain bullish ratings — Goldman Sachs raised its price target to $558 (buy) and Leerink Partners increased its target to $573 (outperform), supporting further upside potential. Goldman Sachs Raises PT Leerink Raises PT TickerReport
• Positive Sentiment: Additional bullish analyst commentary — Truist and Deutsche Bank analysts publicly stated expectations for HCA shares to rise, reinforcing the buy-side momentum. Truist Note Deutsche Bank Note
• Positive Sentiment: Brand and quality recognition — Multiple HCA hospitals placed on Healthgrades’ America’s 50/100/250 Best Hospitals lists, supporting reputation and referral flows. Healthgrades Recognition
• Positive Sentiment: Outpatient growth and M&A runway — Company commentary and industry pieces highlight HCA’s push into outpatient facilities and acquisition opportunities, which investors view as margin‑accretive growth. Outpatient Growth Acquisition Opportunities
• Positive Sentiment: Bullish research notes/coverage — Zacks highlights HCA as a strong growth stock based on style scores, adding to favorable retail/institutional sentiment. Zacks Growth Stock Piece
• Neutral Sentiment: Analysts say the narrative is shifting — Coverage explores how the investment story is evolving post‑earnings/target resets; watch valuation vs. growth expectations. Analyst Narrative
• Neutral Sentiment: Local expansion and competitive landscape — Reporting on new ER builds and regional facility activity (e.g., southwest Florida) that may influence local market share dynamics. Local ER Story Freestanding EDs
• Negative Sentiment: Policy/regulatory risk — HCA is publicly noting it is monitoring federal policy shifts that could affect reimbursement or operations; this is a watcher for downside risk. Policy Risk

HCA Healthcare Trading Up 1.2%

NYSE:HCA opened at $488.19 on Friday. The stock has a market capitalization of $111.40 billion, a PE ratio of 17.20, a price-to-earnings-growth ratio of 1.48 and a beta of 1.36. HCA Healthcare, Inc. has a 12 month low of $295.00 and a 12 month high of $527.55. The firm’s 50 day moving average is $481.07 and its 200 day moving average is $437.35.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. The business had revenue of $19.51 billion for the quarter, compared to analysts’ expectations of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the business posted $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is presently 10.15%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the company. Robert W. Baird boosted their price objective on HCA Healthcare from $423.00 to $450.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Zacks Research cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 27th. Mizuho increased their price target on HCA Healthcare from $505.00 to $520.00 and gave the stock an “outperform” rating in a report on Thursday, December 18th. Oppenheimer upped their price target on HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Wednesday. Finally, Truist Financial boosted their target price on shares of HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a research report on Wednesday. Fifteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $518.76.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.